Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap20.92K
Market cap20.92K
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume18.74K
Average volume18.74K
High today$0.0005
High today$0.0005
Low today$0.0005
Low today$0.0005
Open price$0.0005
Open price$0.0005
Volume13.64K
Volume13.64K
52 Week high$1.27
52 Week high$1.27
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 20.92K, Carisma Therapeutics(CARM) trades at $0.00. The stock has a price-to-earnings ratio of 0.00.
During the trading session on 2026-05-06, Carisma Therapeutics(CARM) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 13.64K, compared to an average daily volume of 18.74K.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $1.27 and a low of $0.00.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $1.27 and a low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.